Dupont Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-926
Closed -$122K 1758
2021
Q1
$122K Sell
926
-2,623
-74% -$359K ﹤0.01% 1337
2020
Q4
$470K Buy
3,549
+492
+16% +$59.5K 0.01% 872
2020
Q3
$312K Buy
3,057
+430
+16% +$37.1K 0.01% 956
2020
Q2
$228K Sell
2,627
-1,424
-35% -$114K 0.01% 1081
2020
Q1
$235K Sell
4,051
-4,755
-54% -$386K 0.01% 962
2019
Q4
$814K Sell
8,806
-52
-0.6% -$4.57K 0.02% 639
2019
Q3
$800K Sell
8,858
-1,852
-17% -$211K 0.02% 596
2019
Q2
$1.26M Buy
10,710
+6,407
+149% +$646K 0.03% 479
2019
Q1
$373K Buy
+4,303
New +$366K 0.01% 868
2018
Q3
Sell
-7,455
Closed -$446K 989
2018
Q2
$446K Sell
7,455
-10,921
-59% -$588K 0.01% 733
2018
Q1
$741K Sell
18,376
-3,903
-18% -$190K 0.02% 597
2017
Q4
$1.17M Buy
22,279
+3,164
+17% +$169K 0.03% 487
2017
Q3
$901K Buy
+19,115
New +$769K 0.02% 546

Other funds holding EXAS

Dupont Capital Management's EXAS Position: Q2 2021 in Review

Dupont Capital Management sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 926 shares — an estimated $122K sold.

Dupont Capital Management first reported a position in EXAS in Q3 2017 and held it in 13 quarters. The position peaked at $1.26M in Q2 2019. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Dupont Capital Management reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Dupont Capital Management sold 926 Exact Sciences shares in Q2 2021, an estimated $122K.
  • Dupont Capital Management first reported a position in Exact Sciences in Q3 2017 and held it in 13 quarters.
  • Dupont Capital Management's Exact Sciences position peaked at $1.26M in Q2 2019.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Dupont Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.